Healthcare technology firm Casana has raised $30m in Series B funding led by Morningside to accelerate the development of its new home health monitoring technology.

Series A investors Outsiders Fund and General Catalyst participated in the funding round, along with private equity investment firm Matrix Partners.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This round has brought the total capital raised by Casana so far to $46m.

Casana intends to use the funds to develop and commercialise its patient-centred health monitoring product, The Heart Seat.

At present, the company is looking to obtain clearance for the product from the US Food and Drug Administration (FDA).

It aims to make the product available for patients this year.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The Heart Seat is an Internet of Things (IoT) health monitoring device that is built into a toilet seat.

It is designed to capture clinically relevant measurements, such as heart rate as well as blood oxygenation and pressure.

On its website, the company claims that the effortless device is developed to monitor patients’ consistent health data and support in-home healthcare management.

The patient-centred health monitoring technology is specially designed for people to manage and control high blood pressure, also called hypertension.

It is claimed to be the first commercial offering developed to monitor cuffless blood pressure.

Casana CEO Austin McChord said: “In a world overrun with push notifications, nudges and reminders, our product needs none of that.

“The Heart Seat is different from virtually every other vitals monitoring product, in that it takes no time out of your day and works best when you forget it’s even there.”

The company is also investing in studies to assess The Heart Seat’s potential value for health systems organisations.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact